Skip to main content
Premium Trial:

Request an Annual Quote

Bionano Genomics, Nvidia Partner to Accelerate Data Processing for Optical Genome Mapping

NEW YORK – Bionano Genomics said on Thursday that it has formed a collaboration with Nvidia to improve data processing speed in order to reduce the time and cost associated with secondary data analysis for Bionano's optical genome mapping (OGM) workflow.

The partners will combine Nvidia’s RTX 6000 Ada Generation GPU with Bionano’s OGM products, aiming to "develop on-premise and cloud-based solutions to keep pace with the anticipated data generation needs of high-throughput OGM workflows," Bionano said.

The computational platform coming out of the project is anticipated to support the analysis of 96 cancer workflows or over 300 constitutional whole genomes per week and to be integrated with Bionano's NxClinical software for variant interpretation and reporting, the company said.

"Bionano is focused on continuous upscaling of our end-to-end genome mapping solutions, and we see this collaboration with Nvidia as an important part of that effort," Bionano President and CEO Erik Holmlin said in a statement. "We believe the solution we're developing with Nvidia will accelerate OGM analysis and enable future expansion into areas including CAR T-cell therapy research and bioprocessing."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.